Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

about

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

Item

http://www.wikidata.org/entity/Q53393752

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@en

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@nl

type

Item

label

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@en

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@nl

prefLabel

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@en

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@nl

P1476

Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.

@en

P2093

Amar G Chittiboyina

http://www.w3.org/2001/XMLSchema#string

Bharathi Avula

http://www.w3.org/2001/XMLSchema#string

Ikhlas A Khan

http://www.w3.org/2001/XMLSchema#string

Larry A Walker

http://www.w3.org/2001/XMLSchema#string

Shabana I Khan

http://www.w3.org/2001/XMLSchema#string

Vamshi K Manda

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline

Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents.

Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism.

Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib.

Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

Radioprotective effects of Aegle marmelos (L.) Correa (Bael): a concise review.

Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

Online sources of herbal product information.

Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.

P304

117-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00498254.2015.1053006

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26247834

http://www.w3.org/2001/XMLSchema#string

P921

ammijin